Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment (AVOID-HF)

This study is currently recruiting participants.
Verified January 2013 by Gambro Renal Products, Inc.
Sponsor:
Collaborator:
Gambro UF Solutions, Inc.
Information provided by (Responsible Party):
Gambro Renal Products, Inc.
ClinicalTrials.gov Identifier:
NCT01474200
First received: November 11, 2011
Last updated: January 30, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)